Cointime update: Moderna reported third-quarter revenue of $1.31 billion, up 29% year over year and above the $888.1 million market estimate. Earnings per share came in at 38 cents versus an expected loss of $1.09, while operating income was $130 million against an expected loss of $471.9 million. R&D spending was $583 million, below the $750 million estimate, and full-year capital expenditure is now expected at $200 million, down from a prior $200 million to $300 million range.
Moderna Q3 revenue $1.31B, up 29% YoY, beating $888.1M estimate
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
3m ago
Morgan Stanley’s Wilson: Nvidia Q3 Results Broadly In Line, AI Still Worth Investing
50m ago
Nvidia beats estimates; analysts flag lingering uncertainty over outlook
1h ago
Binance to Launch USDT Perpetual Contracts for Six TradFi Assets
5h ago
Anthropic Expected to Price IPO Above Range at $80+ Per Share
5h ago
Ark Invest Buys $2.7M of Block Shares as Stock Falls 4.4%
6h ago
Nvidia beats estimates; NVDA perp on Hyperliquid rises 4% to $161.7